Literature DB >> 2890659

Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.

M Cicardi1, T Igarashi, M S Kim, D Frangi, A Agostoni, A E Davis.   

Abstract

Hereditary angioneurotic edema (HANE) results from the deficiency of the inhibitor of the first component of human complement (C1-INH). It is inherited as an autosomal dominant trait. Heterogeneity of this defect has been shown at the protein and mRNA level. Southern blot analysis of genomic DNA was performed after digestion with six different restriction endonucleases in 24 families affected with type 1 HANE (low antigenic and functional C1-INH levels) and five with type 2 (low functional C1-INH levels and normal or elevated levels of dysmorphic C1-INH). Blots were hybridized with a C1-INH cDNA probe of 1,227 bp. With one enzyme (Pst I), two different patterns of restriction fragment length polymorphism (RFLP) were detected. One was present in one kindred with type 1 HANE and the other appeared the same in one type 1 and in one type 2 family, thus indicating that each RFLP resulted from a different mutation. Analysis of a total of 34 members of these three families suggested that the polymorphisms are tightly linked to the mutation responsible for the disease. Using a 170-bp probe we showed that the three different mutations leading to these polymorphisms are located in the same region of the C1-INH gene. These data suggest that different mutations in the same region of the C1-INH gene are responsible for C1-INH deficiency in these families. Most of these mutations are probably point mutations or other "minor" defects and do not appear to be due to major deletions or rearrangements.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890659      PMCID: PMC442434          DOI: 10.1172/JCI113252

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

Authors:  V H DONALDSON; R R EVANS
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease.

Authors:  C M Brickman; G C Tsokos; J E Balow; T J Lawley; M Santaella; C H Hammer; M M Frank
Journal:  J Allergy Clin Immunol       Date:  1986-05       Impact factor: 10.793

3.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  C1 INH concentrate in the therapy of hereditary angioedema.

Authors:  L Bergamaschini; M Cicardi; A Tucci; M Gardinali; D Frangi; C Valle; A Agostoni
Journal:  Allergy       Date:  1983-02       Impact factor: 13.146

5.  DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex.

Authors:  A S Whitehead; D E Woods; E Fleischnick; J E Chin; E J Yunis; A J Katz; P S Gerald; C A Alper; H R Colten
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

6.  Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.

Authors:  J E Gadek; S W Hosea; J A Gelfand; M M Frank
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

Authors:  J A Gelfand; R J Sherins; D W Alling; M M Frank
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

8.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.

Authors:  F S Rosen; C A Alper; J Pensky; M R Klemperer; V H Donaldson
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities.

Authors:  C M Brickman; G C Tsokos; T M Chused; J E Balow; T J Lawley; M Santaella; C H Hammer; G F Linton; M M Frank
Journal:  J Allergy Clin Immunol       Date:  1986-05       Impact factor: 10.793

10.  Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.

Authors:  A E Davis; A S Whitehead; R A Harrison; A Dauphinais; G A Bruns; M Cicardi; F S Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  10 in total

Review 1.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

2.  Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene.

Authors:  N J Levy; N Ramesh; M Cicardi; R A Harrison; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.

Authors:  T Ariga; T Igarashi; N Ramesh; R Parad; M Cicardi; A E Davis
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

4.  Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema.

Authors:  D Frangi; M Cicardi; A Sica; F Colotta; A Agostoni; A E Davis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

5.  Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.

Authors:  J Kramer; Y Katz; F S Rosen; A E Davis; R C Strunk
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 6.  Genetics of Hereditary Angioedema Revisited.

Authors:  Anastasios E Germenis; Matthaios Speletas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 7.  Pathophysiology of Hereditary Angioedema.

Authors:  Sonia Caccia; Chiara Suffritti; Marco Cicardi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-12-01       Impact factor: 1.349

8.  Life-threatening laryngeal oedema in a pregnant woman with hereditary angioedema.

Authors:  P G McGlinchey; K Golchin; D R McCluskey
Journal:  Ulster Med J       Date:  2000-05

9.  Collaboration for rare disease drug discovery research.

Authors:  Nadia K Litterman; Michele Rhee; David C Swinney; Sean Ekins
Journal:  F1000Res       Date:  2014-10-31

10.  Genetic variants of SERPING1 gene in Polish patients with hereditary angioedema due to C1 inhibitor deficiency.

Authors:  Krystyna Obtulowicz; Teofila KsiĄŻek; Anna Bogdali; Wojciech Dyga; Ewa Czarnobilska; Aldona Juchacz
Journal:  Cent Eur J Immunol       Date:  2020-11-01       Impact factor: 2.085

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.